Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105580

Blood Cholesterol and Hydrocortisone Production in Man: Quantitative Aspects of the Utilization of Circulating Cholesterol by the Adrenals at Rest and under Adrenocorticotropin Stimulation

Abraham J. Borkowski, Sam Levin, Claude Delcroix, Antoinette Mahler, and Vera Verhas

Service of Medicine and Clinical Investigation, Institut Jules Bordet, Centre Anticancereux de l'Université Libre de Bruxelles, Brussels, Belgium

Central Laboratory of Nuclear Medicine, Brussels, Belgium

†

Address requests for reprints to Dr. A. J. Borkowski, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, Bruxelles, Belgium.

‡

Supported in part by contract Euratom-ULB-Pisa (0.26-63-4 B.I.A.C.).

*

Submitted for publication January 10, 1966; accepted January 27, 1967.

Find articles by Borkowski, A. in: PubMed | Google Scholar

Service of Medicine and Clinical Investigation, Institut Jules Bordet, Centre Anticancereux de l'Université Libre de Bruxelles, Brussels, Belgium

Central Laboratory of Nuclear Medicine, Brussels, Belgium

†

Address requests for reprints to Dr. A. J. Borkowski, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, Bruxelles, Belgium.

‡

Supported in part by contract Euratom-ULB-Pisa (0.26-63-4 B.I.A.C.).

*

Submitted for publication January 10, 1966; accepted January 27, 1967.

Find articles by Levin, S. in: PubMed | Google Scholar

Service of Medicine and Clinical Investigation, Institut Jules Bordet, Centre Anticancereux de l'Université Libre de Bruxelles, Brussels, Belgium

Central Laboratory of Nuclear Medicine, Brussels, Belgium

†

Address requests for reprints to Dr. A. J. Borkowski, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, Bruxelles, Belgium.

‡

Supported in part by contract Euratom-ULB-Pisa (0.26-63-4 B.I.A.C.).

*

Submitted for publication January 10, 1966; accepted January 27, 1967.

Find articles by Delcroix, C. in: PubMed | Google Scholar

Service of Medicine and Clinical Investigation, Institut Jules Bordet, Centre Anticancereux de l'Université Libre de Bruxelles, Brussels, Belgium

Central Laboratory of Nuclear Medicine, Brussels, Belgium

†

Address requests for reprints to Dr. A. J. Borkowski, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, Bruxelles, Belgium.

‡

Supported in part by contract Euratom-ULB-Pisa (0.26-63-4 B.I.A.C.).

*

Submitted for publication January 10, 1966; accepted January 27, 1967.

Find articles by Mahler, A. in: PubMed | Google Scholar

Service of Medicine and Clinical Investigation, Institut Jules Bordet, Centre Anticancereux de l'Université Libre de Bruxelles, Brussels, Belgium

Central Laboratory of Nuclear Medicine, Brussels, Belgium

†

Address requests for reprints to Dr. A. J. Borkowski, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, Bruxelles, Belgium.

‡

Supported in part by contract Euratom-ULB-Pisa (0.26-63-4 B.I.A.C.).

*

Submitted for publication January 10, 1966; accepted January 27, 1967.

Find articles by Verhas, V. in: PubMed | Google Scholar

Published May 1, 1967 - More info

Published in Volume 46, Issue 5 on May 1, 1967
J Clin Invest. 1967;46(5):797–811. https://doi.org/10.1172/JCI105580.
© 1967 The American Society for Clinical Investigation
Published May 1, 1967 - Version history
View PDF
Abstract

A kinetic study of the conversion of blood cholesterol into hydrocortisone was carried out in two patients through prolonged infusions of cholesterol-4-14C. The following points appear to be established by our observations:

1) The infused tracer behaved metabolically like endogenous cholesterol; it could therefore serve as a means of labeling plasma cholesterol for investigating its utilization by the adrenal cortex.

2) At rest, about 80% of hydrocortisone derived from plasma cholesterol, the other 20% thus being synthesized in situ from acetate and other unlabeled precursors.

3) Under ACTH stimulation the participation of plasma cholesterol in the synthesis of hydrocortisone was the same as at rest; the conversion of plasma cholesterol into hydrocortisone was thus proportional to the production of glucocorticosteroids by the adrenal glands.

4) The specific activities of hydrocortisone allowed us to trace its adrenal precursors including adrenal cholesterol. The kinetics of the replacement of adrenal cholesterol by plasma cholesterol underlined the functional heterogeneity of the former. The experimental data were compatible with the following model: A fraction of plasma cholesterol entering the adrenal cell is immediately available for metabolism and conversion into steroid hormones, and another fraction turns over slowly, representing some form of storage.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 797
page 797
icon of scanned page 798
page 798
icon of scanned page 799
page 799
icon of scanned page 800
page 800
icon of scanned page 801
page 801
icon of scanned page 802
page 802
icon of scanned page 803
page 803
icon of scanned page 804
page 804
icon of scanned page 805
page 805
icon of scanned page 806
page 806
icon of scanned page 807
page 807
icon of scanned page 808
page 808
icon of scanned page 809
page 809
icon of scanned page 810
page 810
icon of scanned page 811
page 811
Version history
  • Version 1 (May 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts